Overview
ITI Pharma and Healthcare Fund Direct Growth
ITI Mutual Fund
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.
Investments in ITI Pharma and Healthcare Fund Direct Growth are subject to market risks. Please read the offer document carefully before investing to understand the potential market risks and rewards.
Latest NAV
₹ 17.0668
Fund Size (AUM)
₹213.78 Cr
Risk
Very High (Risk rating: 6/10)
Minimum Investment
Lumpsum: ₹ 5000
SIP: ₹500
Launch Date
08-Nov-2021
Expense Ratio
0.47%
Exit Load
Exit load of 1% if redeemed within 12 months.
Benchmark
NIFTY Healthcare Total Return Index.
Standard Deviation
16.41
History
Performance & Ratios
1-Year SIP Return
-4.18%
3-Year SIP Return
21.99%
5-Year SIP Return
N/A
Mean Return
N/A
Alpha
0.95
Beta
0.93
Sharpe Ratio
0.85
Sortino Ratio
1.25
Information Ratio
0.01
Returns
| 1Y | 3Y | 5Y | All Time | |
|---|---|---|---|---|
| Fund Returns | 21.37% | 20.42% | N/A | N/A |
| Category Average | 19.46% | 17.92% | 21.75% | N/A |
| Rank Within Category | 8 | 6 | N/A | N/A |
Holdings (39)
| Company | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 16.22% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 5.96% |
| Lupin Ltd. | Healthcare | Equity | 5.78% |
| Suven Pharmaceuticals Ltd. | Healthcare | Equity | 5.39% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 5.16% |
| Max Healthcare Institute Ltd. | Healthcare | Equity | 5.07% |
| Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 4.11% |
| Aurobindo Pharma Ltd. | Healthcare | Equity | 3.61% |
| Mankind Pharma Ltd. | Healthcare | Equity | 3.09% |
| Alkem Laboratories Ltd. | Healthcare | Equity | 2.84% |
Holdings Analysis
Peer Comparison
SIP, STP & SWP Details
Systematic Investment Plan (SIP):
Frequency: Monthly
Min Amount: ₹ 500
Multiplier: 1
Systematic Transfer Plan (STP):
Frequency: MONTHLY
Dates: 1, 7, 14, 21, 28
Min Amount: ₹ 1000
Min Installments: 2
Systematic Withdrawal Plan (SWP):
Frequency: MONTHLY
Dates: 1, 7, 14, 21, 28
Min Amount: ₹ 1000
Min Installments: 2
AMC Details
Asset Management Company
ITI Mutual Fund
None ITI Mutual Fund employs robust strategies to manage market risks, but investments remain subject to market risks. Please read the fund’s documentation for detailed risk management policies.
Launch Date
2018-05-14T00:00:00.945Z
Total AUM
₹ 9273.61 Cr
Address
ITI Asset Mangement Limited,ITI House, Building no. 36,Dr. R. K. Shirodkar Marg, Parel, Mumbai 400012
Phone
022-66214999
Website
Sub Type
Contra
Sub Type Info
Contra funds follow Contrarian strategy which means investing in stocks in contrast to the prevailing sentiment. Minimum investment in equity is 65%.
Tax Impact
Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.
Stamp Duty
0.005% (from July 1st, 2020)
Fund Manager Details
Compare with Another Fund
ITI Pharma and Healthcare Fund Direct Growth
ITI Mutual Fund
You May Be Interested In
HSBC Midcap Fund Direct Growth
Mid Cap
Navi Nifty Midcap 150 Index Fund Direct Growth
Mid Cap
PGIM India Flexi Cap Fund Direct Growth
Flexi Cap
Aditya Birla Sun Life Nifty Midcap 150 Index Fund Direct Growth
Mid Cap
Canara Robeco Flexi Cap Fund Direct Growth
Flexi Cap
Axis Nifty Midcap 50 Index Fund Direct Growth
Mid Cap
Tata Flexi Cap Fund Direct Growth
Flexi Cap
Axis Nifty 100 Index Fund Direct Growth
Large Cap
LIC MF Large & Mid Cap Fund Direct Growth
Large & MidCap
Edelweiss NIFTY Large Mid Cap 250 Index Fund Direct Growth
Large & MidCap
Explore More Mutual Funds
Debt Mutual Funds - Best Debt Fund Options
Discover top debt mutual funds for stable returns. Filter by NAV, fund size, and AMC to find the best debt funds for you.
Hybrid Mutual Funds - Top Hybrid Funds
Find top hybrid mutual funds for balanced growth. Filter by NAV, fund size, and risk to choose the best hybrid funds.
Commodities Mutual Funds
Explore commodities mutual funds for diversification. Filter by NAV and fund size to find the best commodity funds.
ELSS Mutual Funds - Top Tax-Saving Funds
Discover top ELSS mutual funds for tax savings and growth. Filter by NAV, fund size, and AMC to find the best ELSS funds.
Frequently Asked Questions
How is the overall rating calculated?
The overall rating for ITI Pharma and Healthcare Fund Direct Growth is an aggregate score based on performance metrics (returns over 1, 3, and 5 years), risk-adjusted returns (Sharpe and Sortino ratios), and consistency relative to its category. Ratings are on a scale of 1 to 5, with 5 being the highest.
What are the top stocks of ITI Pharma and Healthcare Fund Direct Growth?
The top stocks held by ITI Pharma and Healthcare Fund Direct Growth include Sun Pharmaceutical Industries Ltd., Divi's Laboratories Ltd., Lupin Ltd..
Which industries does ITI Pharma and Healthcare Fund Direct Growth invest in?
ITI Pharma and Healthcare Fund Direct Growth primarily invests in the following industries: Healthcare, Chemicals, Diversified.
Who are the fund managers of ITI Pharma and Healthcare Fund Direct Growth?
The fund managers of ITI Pharma and Healthcare Fund Direct Growth are Dhimant Shah and Rohan Korde and Rajesh Bhatia.
How many years has the fund manager been managing ITI Pharma and Healthcare Fund Direct Growth?
Dhimant Shah:
Calculating...
Rohan Korde:
Calculating...
Rajesh Bhatia:
Calculating...
What is the minimum investment for ITI Pharma and Healthcare Fund Direct Growth?
The minimum investment for ITI Pharma and Healthcare Fund Direct Growth is ₹5000 for lumpsum investments and ₹500 for SIPs.
What are the average 1-year returns for ITI Pharma and Healthcare Fund Direct Growth?
Calculating...
What are the average 3-year returns for ITI Pharma and Healthcare Fund Direct Growth?
Calculating...
What is the expense ratio of ITI Pharma and Healthcare Fund Direct Growth, and how does it compare to its category?
The expense ratio of ITI Pharma and Healthcare Fund Direct Growth is 0.47%. No category comparison data is available.